Stark Associates Insurance Agency

Great day between the rain drops Jersey Shore BlueClaws and meeting up with old friends in the medical insurance industry NABIP-NJ

Medicare continues to evolve, and one of the latest proposed changes from the Trump Administration is the decision to end a Medicare prescription drug subsidy program that was created as a temporary measure to help stabilize premiums in the Medicare Part D market.

The Trump Administration has announced its intention to discontinue this temporary subsidy program.

The administration has stated that the subsidy was always intended to be a short-term solution rather than a permanent feature of Medicare Part D. As a result, insurers will need to price their prescription drug plans without this additional federal financial assistance.

While the exact impact will vary by insurance carrier and plan, beneficiaries could see changes when new Part D plans are released for future enrollment periods.

Although it’s too early to know exactly how every plan will be affected, several outcomes are possible:

• Some Medicare Part D premiums may increase.
• Insurance companies may redesign their formularies (covered drug lists).
• Copays or coinsurance for certain medications could change.
• Some plans may adjust pharmacy networks or utilization management requirements.

It’s important to remember that these changes will not affect every Medicare plan equally. Some carriers may absorb more of the costs than others.

Tap the link on our profile to learn more 🔗 bit.ly/starkassociates

Thanks so much, Lori! 🌟 📲 732.217.4707 🔗 bit.ly/starkassociates